Analyze Diet

Control of estrus with prostaglandin F2alpha in mares: minimal effective dose and stage of estrous cycle.

Abstract: To determine the minimal effective dose of prostagiandin (PGF2alpha; tromethamine salt) given subcutaneously (SC), mares of mixed breeding (400 kg av body weight) were given 2-, 3-, 5-, and 10-mg doses from 7 to 9 days after ovulation. In some but not all mares given doses of 2 and 3 mg of PGF2alpha, luteolysis occurred, but doses of 5 or 10 mg of PGF2alpha were luteolytic in all mares. The 10-mg dose of PGF2alpha did not cause luteolysis in mares 1 day after ovulation, and caused luteolysis in only 2 of 5 mares on day 3 after ovulation. The same dose of PGF2alpha, however, caused luteolysis in all mares on days 5 or 7 after ovulation. The results indicate that the minimal effective luteolytic dose of PGF2alpha (free-acid equivalent) is about 9 mug/kg, and that PGF2alpha is effective fromday 5 after ovulation.
Publication Date: 1975-08-01 PubMed ID: 1171645
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research aimed to identify the minimal dose of a specific hormone (prostaglandin F2alpha) that can effectively suppress estrus (a period of sexual receptivity) in horses, and figured out the effectiveness of the hormone at various stages of the horse’s sexual cycle.

Understanding the Objective

  • This research focused on understanding the effect of different doses of a hormone called prostaglandin F2alpha (PGF2alpha) on the estrus cycle in mares. The hormone was given subcutaneously (under the skin).
  • The study looked to determine the minimal dose of the hormone that could effectively cause luteolysis (the breakdown of the corpus luteum, which signals the end of the estrus cycle) ensuring sufficient hormonal balance for mares’ health.

Methodology

  • PGF2alpha was administered in varying doses (2, 3, 5, and 10 milligrams) to mares of mixed breeding with an average body weight of 400 kilograms.
  • The doses were given from 7 to 9 days after ovulation, to see the effect of these doses on the post-ovulation phase of the estrus cycle in mares.

Findings

  • It was observed that low doses (2 and 3 milligrams) of PGF2alpha could cause luteolysis in some mares. However, in doses of 5 or 10 milligrams, the hormone was able to cause luteolysis in all mares, confirming that these higher doses have a definite effect.
  • The 10-milligram dose did not cause luteolysis in mares who were only 1 day past ovulation, and only had this effect on 2 out of 5 mares on the 3rd day past ovulation.
  • However, when administered 5 or 7 days after ovulation, the 10-milligram dose was effective in causing luteolysis in all mares tested.

Conclusion

  • The study concludes that the minimum effective dose of PGF2alpha needed for luteolysis is about 9 μg/kg.
  • Furthermore, the study found that PGF2alpha is effective from day 5 post-ovulation. This suggests that its administration should be timed appropriately for maximum effectiveness during the estrus cycle of mares.

Cite This Article

APA
Oxender WD, Noden PA, Bolenbaugh DL, Hafs HD. (1975). Control of estrus with prostaglandin F2alpha in mares: minimal effective dose and stage of estrous cycle. Am J Vet Res, 36(08), 1145-1147.

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 36
Issue: 08
Pages: 1145-1147

Researcher Affiliations

Oxender, W D
    Noden, P A
      Bolenbaugh, D L
        Hafs, H D

          MeSH Terms

          • Animals
          • Estrus / drug effects
          • Female
          • Horses / physiology
          • Injections, Subcutaneous
          • Ovarian Follicle / growth & development
          • Ovulation
          • Pregnancy
          • Progesterone / blood
          • Prostaglandins F / administration & dosage
          • Prostaglandins F / pharmacology
          • Time Factors

          Citations

          This article has been cited 0 times.